Inamed fat products buck thin sales trend:
This article was originally published in Clinica
Executive Summary
Surgical and medical device company Inamed said that its second-quarter sales were down by 4.5%, due to lower breast implant prices and poor sales of collagen products in Europe. The company blamed mad cow disease for falling collagen sales, but said that obesity products were strong in "the first half of the second quarter".